Form 425 - Prospectuses and communications, business combinations
14 Septembre 2023 - 5:19PM
Edgar (US Regulatory)
Filed by Aegon N.V.
Pursuant to Rule 425 Under the Securities Act of 1933
Subject Company: Aegon N.V.
Commission File No.: 1-10882
Form F-4 Registration No.: 333-273041
The Hague, 14 September 2023
Response to updated 2023 Glass Lewis September EGM Proxy Report dated 13 September 2023
Dear Shareholders,
Aegon N.V. has taken note of the
updated Glass Lewis EGM Proxy Report dated 13 September 2023 relating to the Aegon EGMs on 29 and 30 September 2023. By means of this rebuttal, Aegon would like to express its strong disagreement with the recommendation contained
therein to shareholders to vote against the proposal to redomicile Aegon N.V. from the Netherlands to Bermuda.
Aegon believes that there is a
compelling rationale for Aegon changing its domicile to Bermuda, and believes that a full appreciation of both the strategic rationale and the proposed governance is in the interest of Aegon and its stakeholders, including its shareholders.
|
|
|
Following the closing of the transaction with a.s.r. on July 4th Aegon no longer has a regulated insurance
activity in the Netherlands. At the same time, the combination with a.s.r. has resulted in a transformational shift in the geographical footprint of Aegon Group. While Aegon continues to have a part of its global asset management activities in the
Netherlands, the overwhelming majority of its business activities (more than 99% of shareholders equity) is outside of the Netherlands. The reality is that Aegon today is an international insurance and asset management company and no longer a
Dutch company. |
|
|
|
The transaction also has had significant regulatory implications. As a consequence of the fact that Aegon no
longer has a regulated insurance business in the Netherlands, there is no legal basis for the Dutch Central Bank to continue as Aegons group regulator. At the same time, as long as Aegon N.V. keeps its legal seat in the European Union
(EU), Solvency II will apply to Aegon Group. Since over 99.5% of Aegons insurance businesses as measured by total assets are not located in the EU (where Solvency II is the governing capital framework), Aegon does not
believe that it is appropriate to continue to be subject to group supervision under that framework. |
|
|
|
If Aegon would not take action, according to Solvency II regulation the role of group supervisor would be
allocated to Aegons largest business in the EU, i.e. Spain (DGSFP). For multiple reasons, we believe this alternative is not suitable. First, Aegon does not believe Solvency II is the appropriate framework for our group. Second, Spain
(where Aegons activities represent less than 1% of Aegons balance sheet) is not appropriate as group supervisor. DGSFP has issued a clear statement, which you can find on our website, supporting supervision by the Bermuda
Monetary Authority (BMA) and clarifying why it does not find itself suitable as group regulator. Third, in its statement DGSFP indicated it would revisit a number of key items of our capital management processes including the application of
the internal model, which would lead to material uncertainty as to Aegons capital management approach. |
|
|
|
It is for these reasons that, after intensive discussions with our college of supervisors and after exploring
various alternatives, Aegon decided that moving our legal seat to Bermuda to facilitate group supervision by the BMA is the most appropriate way of enabling effective group supervision compatible with the geographic footprint of Aegon Group. Aegon
has agreed transitional arrangements with the BMA providing shareholders with the necessary stability in Aegons capital management framework while setting Aegon up for continued future success. In this context, the Aegon boards have proposed
what Aegon firmly believes is a robust governance framework befitting a company with the profile and geographic footprint of Aegon based on Bermuda. |
|
|
|
Aegon has had intensive engagement regarding the proposed governance with its shareholders and representative
organizations throughout the summer. This has resulted in Aegon making two meaningful adjustments in order to address the concerns of some of these organizations. The response from shareholders received so far has been positive.
|
|
|
|
Despite this transformational shift in the geographical footprint of Aegon Group, and the reality of the
regulatory complexity Aegon has to navigate, Glass Lewis continues to measure the governance of Aegon Ltd against typical Dutch governance arrangements and uses that as the basis for its recommendation. This goes particularly for the remuneration
policy of the board. First, Bermuda law does not provide for any shareholder vote on director remuneration. To further strengthen the position of shareholders in this respect, Aegon has voluntarily included that the remuneration policy of the board
is to be adopted by its shareholders by simple majority. Glass Lewis however focuses on the provision in Dutch law that requires a 75% majority for the adoption of the remuneration policy. This supermajority requirement is unique for the Netherlands
and is not applied internationally.1 Aegon strongly disagrees with this approach as it is of the view that a more international governance standard is a better fit for the more international and
less Dutch profile of Aegon. |
|
|
|
The implied suggestion from Glass Lewis is to reverse all governance proposals that they view as detrimental and
to apply the existing Dutch governance to a Bermuda based entity. In doing so, Glass Lewis does not appear to recognize the importance of the changes in the footprint of Aegon Group, nor the inability or impracticability to apply Dutch legal
concepts in a Bermuda context. For example, Bermuda law is not familiar with the concept of annual discharge of board members and, accordingly, such vote would not have any effect as such vote is inapplicable under Bermuda law.
|
|
|
|
Therefore, Glass Lewis highlights a number of limited changes to shareholder rights as being negative, the
totality of which, in Aegons view, do not warrant an against recommendation. This is especially true when balanced against the importance of continuity of and certainty around supervision and capital management for Aegon.
|
Aegon will continue the active engagement with its stakeholders, including its shareholders, in preparation for the EGMs on 29 and
30 September as we believe that the proposed resolution is in the best interest of all shareholders.
We therefore urge shareholders to support all
resolutions put forward at the Extraordinary General Meetings to be held on 29 and 30 September 2023. We welcome any further views and discussion on this agenda item ahead of, and during the upcoming EGM. If you would like to discuss the EGM
proposals with us, please contact:
Mr Hielke Hielkema (Head of Investor Relations ad interim)
Direct: +31 6 3028 8436
Email:
hielke.hielkema@aegon.com
1 |
See for example the Glass Lewis report SRD II Say on Pay requirements An overview
of Key Changes and the Glass Lewis Approach. |
2
Notice to U.S. shareholders In connection with the proposed Redomiciliation, Aegon N.V. has filed with the
U.S. Securities and Exchange Commission (SEC) a registration statement on Form F-4 (Registration No. 333-273041), which became effective on
July 21, 2023, that includes a U.S. Shareholder Circular that you are encouraged to review carefully before making any decisions regarding the proposed Redomiciliation. This Convocation and Agenda with Explanatory Notes does not constitute an
offer to sell or the solicitation of an offer to buy any securities and is not a substitute for the U.S. Shareholder Circular or any other document that Aegon N.V. may file with the SEC or send to U.S. shareholders in connection with the proposed
Redomiciliation. U.S. SHAREHOLDERS OF AEGON N.V. ARE URGED TO READ ALL RELEVANT DOCUMENTS FILED WITH THE SEC, INCLUDING THE FINAL U.S. SHAREHOLDER CIRCULAR, BECAUSE THEY CONTAIN IMPORTANT INFORMATION ABOUT AEGON LTD. AND THE PROPOSED
REDOMICILIATION. This information is available to you without charge upon your written or oral request. You will be able to obtain the documents free of charge at the SECs website, http://www.sec.gov. In addition, the documents may be obtained
in hard copy free of charge by directing a request in writing or by telephone to Aegon N.V. at Aegonplein50; 2591 TV The Hague; the Netherlands; Attention: Investor Relations or by e-mail at ir@aegon.com, or
by calling our agent for service in the United States of America Andrew S. Williams Telephone: +1 443 475 3243
3
Aegon (NYSE:AEG)
Graphique Historique de l'Action
De Nov 2024 à Déc 2024
Aegon (NYSE:AEG)
Graphique Historique de l'Action
De Déc 2023 à Déc 2024